Eterna Therapeutics News - ERNA

Company Name	Stock Ticker Symbol	Market	Type
Eterna Therapeutics Inc	ERNA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.1549	-7.24%	1.9851	15:00:50

Open Price	Low Price	High Price	Close Price	Prev Close
2.15	1.9353	2.20		2.14

more quote information »

Recent News

Date	Time	Source	Heading
2/20/2024	08:30	GLOBE	Eterna Therapeutics Announces the Appointment of Peter..
2/16/2024	17:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2/16/2024	07:30	EDGAR2	Form 8-K - Current report
1/31/2024	07:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/24/2024	16:15	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/23/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/19/2024	16:16	EDGAR2	Form 8-K - Current report
1/19/2024	10:31	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/16/2024	16:16	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
1/12/2024	16:49	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/03/2024	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	17:01	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
1/03/2024	16:15	GLOBE	Eterna Therapeutics Grants New President and CEO Sanjeev..
12/22/2023	12:05	EDGAR2	Form SC 13D/A - General statement of acquisition of..
12/20/2023	16:20	EDGAR2	Form 8-K - Current report
12/20/2023	16:15	GLOBE	Eterna Therapeutics Names Sanjeev Luther as President and..
12/20/2023	15:24	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/20/2023	10:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/18/2023	21:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/14/2023	18:56	GLOBE	Eterna Therapeutics Announces $9.2 Million Convertible Debt..
12/14/2023	16:30	EDGAR2	Form 8-K - Current report
11/16/2023	16:16	EDGAR2	Form 8-K - Current report
11/13/2023	17:30	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/13/2023	08:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	08:34	EDGAR2	Form 8-K - Current report
11/01/2023	08:30	GLOBE	Eterna Therapeutics Appoints James Bristol, Ph.D.,..
10/05/2023	16:30	EDGAR2	Form 8-K - Current report
9/26/2023	16:30	EDGAR2	Form 8-K/A - Current report: [Amend]
9/08/2023	06:07	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
9/07/2023	17:26	EDGAR2	Form SC 13D/A - General statement of acquisition of..
9/06/2023	08:00	GLOBE	Eterna Therapeutics Announces Initiation of Development..
9/05/2023	08:30	GLOBE	Eterna Therapeutics Appoints Biopharma Industry Veteran..
9/01/2023	17:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/31/2023	16:15	EDGAR2	Form 8-K - Current report
8/28/2023	16:57	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
8/25/2023	19:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	07:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/2023	16:59	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/11/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/10/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/10/2023	16:10	EDGAR2	Form 8-K - Current report
8/02/2023	17:25	EDGAR2	Form 8-K - Current report
7/26/2023	17:05	EDGAR2	Form SC 13D/A - General statement of acquisition of..
7/18/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/18/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/18/2023	08:05	EDGAR2	Form 8-K - Current report
7/18/2023	08:00	GLOBE	Eterna Therapeutics Announces Completion of $8.7 Million of..
7/18/2023	06:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..